Endometrial cancer is still serious in the mid to late stages and requires aggressive intervention for treatment.
Endometrial cancer has a higher survival rate compared to other cancers, but it is related to the specific stage. Early stage has better prognosis, and after standard treatment such as surgery, radiotherapy, chemotherapy, etc., the 5-year survival rate is very high, but the survival rate of endometrial cancer in middle and late stage decreases significantly after standard treatment, so endometrial cancer is more serious in middle and late stage.
Endometrial cancer is one of the three most common gynecologic malignancies and is more common in perimenopausal and postmenopausal women. The main manifestations include vaginal bleeding and abnormal vaginal discharge, etc. The cause of the disease is not clear at present, and it may be related to estrogen and gene mutation.
If vaginal bleeding occurs in postmenopausal women, it is recommended to seek timely medical examination to clarify the cause and actively treat it if necessary. In order to obtain a better therapeutic effect and prognosis.